AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT

Major advancements in the development of ATL-105 for the treatment of inflammatory lung diseases: Clinical trial in non-cystic fibrosis bronchiectasis (NCFB) to start in 2025 ­Pre